科学技術産業
From Mainland China

Great Bay Bio

Great Bay Bio (GBB), founded in Hong Kong in 2019, is an innovative BioTech company with a vision to make global bioprocessing simpler and more efficient. Committed to utilising artificial intelligence (AI) and other cutting-edge technologies, GBB aims to address the challenges of long timelines, high costs, and low success rates in medicine developments, as well as other industries involving bioprocessing. Occupying 3,000 m2, GBB’s research and development centre is located in Dongguan, Guangdong and is led by a team of experienced professionals in biopharmaceuticals and AI.

GBB has launched multiple proprietary AI BioTech platforms and had a total of over 50 patent applications with over 40 patents related to AI BioTech platforms.

As of the end of 2022, GBB has completed three financing rounds, raising over US$30 million.

21.08.2023
Bio Technology
https://greatbay-bio.com
21.08.2023
お問い合わせ
ご連絡先をお知らせください。折り返しご連絡いたします。

The personal information you have provided will help us deliver, develop and promote our services. By submitting your details, ticking the boxes and clicking "Submit" indicate that you have read and agreed to our privacy policy and cookie policy. Please read these to understand your data rights.